Significance of the orexinergic system in modulating stress-related responses in an animal model of post-traumatic stress disorder

• Published in: Translational psychiatry Vol. 10; no. 1; p. 10
• Main Authors: Cohen, Shlomi, Matar, Michael A, Vainer, Ella, Zohar, Joseph, Kaplan, Zeev, Cohen, Hagit
• Format: Journal Article
• Language: English
• Published: United States Nature Publishing Group 21.01.2020; Nature Publishing Group UK
• Subjects: Animals; Behavior; Brain-derived neurotrophic factor; Disease Models, Animal; Genotype & phenotype; Neuropeptide Y; Post traumatic stress disorder; Prospective Studies; Rats; Rats, Sprague-Dawley; Stress Disorders, Post-Traumatic
• ISSN: 2158-3188; 2158-3188
• DOI: 10.1038/s41398-020-0698-9

Converging evidence indicates that orexins (ORXs), the regulatory neuropeptides, are implicated in anxiety- and depression-related behaviors via the modulation of neuroendocrine, serotonergic, and noradrenergic systems. This study evaluated the role of the orexinergic system in stress-associated physiological responses in a controlled prospective animal model. The pattern and time course of activation of hypothalamic ORX neurons in response to predator-scent stress (PSS) were examined using c-Fos as a marker for neuronal activity. The relationship between the behavioral response pattern 7 days post-exposure and expressions of ORXs was evaluated. We also investigated the effects of intracerebroventricular microinfusion of ORX-A or almorexant (ORX-A/B receptor antagonist) on behavioral responses 7 days following PSS exposure. Hypothalamic levels of ORX-A, neuropeptide Y (NPY), and brain-derived neurotrophic factor (BDNF) were assessed. Compared with rats whose behaviors were extremely disrupted (post-traumatic stress disorder [PTSD]-phenotype), those whose behaviors were minimally selectively disrupted displayed significantly upregulated ORX-A and ORX-B levels in the hypothalamic nuclei. Intracerebroventricular microinfusion of ORX-A before PSS reduced the prevalence of the PTSD phenotype compared with that of artificial cerebrospinal fluid or almorexant, and rats treated with almorexant displayed a higher prevalence of the PTSD phenotype than did untreated rats. Activated ORX neurons led to upregulated expressions of BDNF and NPY, which might provide an additional regulatory mechanism for the modulation of adaptive stress responses. The study indicates that the activated ORX system might promote adaptive responses to PSS probably via stimulation of BDNF and NPY secretion, and early intervention with ORX-A reduces the prevalence of the PTSD phenotype and increases the prevalence of adaptive phenotypes. The findings provide some insights into the mechanisms underlying the involvement of the ORX system in stress-related disorders.